Omnaris and Melatonin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Omnaris (ciclesonide) and Melatonin (melatonin). Common drug interactions include adrenal insufficiency among females and gait disturbance among males.

The phase IV clinical study analyzes what interactions people have when they take Omnaris and Melatonin. It is created by eHealthMe based on reports of 31 people who take the same drugs from the FDA, and is updated regularly.

What is Omnaris?

Omnaris has active ingredients of ciclesonide. It is often used in allergies. eHealthMe is studying from 3,970 Omnaris users. Check the latest studies of Omnaris.

What is Melatonin?

Melatonin has active ingredients of melatonin. It is often used in insomnia. eHealthMe is studying from 56,212 Melatonin users. Check the latest studies of Melatonin.



On Aug, 09, 2026

31 people who take Omnaris and Melatonin together, and have interactions are studied.

Omnaris and Melatonin drug interactions.

What are the common drug interactions of Omnaris and Melatonin, by gender? *:

female:

  1. Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
  2. Urticaria (rash of round, red welts on the skin that itch intensely)
  3. Arthralgia (joint pain)
  4. Cerebral haemorrhage (bleeding within the brain)
  5. Erythema (redness of the skin)
  6. Fatigue (feeling of tiredness)
  7. Hypertension (high blood pressure)
  8. Hypotension (abnormally low blood pressure)
  9. Ocular discomfort (a generic expression when there is lack of ease in/about the eyes)
  10. Palpitations (feelings or sensations that your heart is pounding or racing)

male:

  1. Gait disturbance
  2. Asthenia (weakness)
  3. Decreased appetite
  4. Diarrhoea
  5. Haematoma (collection of blood outside the blood vessels)
  6. Haemorrhage (bleeding)
  7. Vomiting

What are the common drug interactions of Omnaris and Melatonin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Gait disturbance
  2. Haematoma (collection of blood outside the blood vessels)
  3. Haemorrhage (bleeding)

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
  2. Arthralgia (joint pain)
  3. Cerebral haemorrhage (bleeding within the brain)
  4. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  5. Dizziness
  6. Erythema (redness of the skin)
  7. Fatigue (feeling of tiredness)
  8. Headache (pain in head)
  9. Hypertension (high blood pressure)
  10. Hypotension (abnormally low blood pressure)

50-59:

  1. Bronchial hyperreactivity
  2. Dehydration (dryness resulting from the removal of water)
  3. Dysphonia (speech disorder attributable to a disorder of phonation)
  4. Escherichia urinary tract infection (urinary tract infection by escherichia coli)
  5. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)

60+:

  1. Back pain
  2. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  3. Pain
  4. Somnolence (a state of near-sleep, a strong desire for sleep)
  5. Urticaria (rash of round, red welts on the skin that itch intensely)
  6. Asthenia (weakness)
  7. Decreased appetite
  8. Diarrhoea
  9. Ear discomfort
  10. Faecaloma (hard mass of fecal matter)

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 12 people, 38.71%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 5 people, 16.13%
  3. Urticaria (rash of round, red welts on the skin that itch intensely): 3 people, 9.68%
  4. Fibromyalgia (a long-term condition which causes pain all over the body): 3 people, 9.68%
  5. Angioedema (rapid swelling of the dermis): 3 people, 9.68%
  6. Nasal Congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels): 2 people, 6.45%
  7. Multiple Myeloma (cancer of the plasma cells): 2 people, 6.45%
  8. Endometrial Hyperplasia (enlargement of uterus wall): 2 people, 6.45%
  9. Asthma: 2 people, 6.45%

* Approximation only. Some reports may have incomplete information.

Do you take Omnaris and Melatonin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Omnaris and Melatonin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Omnaris:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Melatonin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Omnaris and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Melatonin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ciclesonide and melatonin (the active ingredients of Omnaris and Melatonin, respectively), and Omnaris and Melatonin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: